-
Mashup Score: 5
Welcome! You are invited to join a webinar: Frontiers in Cardiovascular Science Seminar. After registering, you will receive a confirmation email about joining the webinar.
Source: ZoomCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 0Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline‐Induced Cardiomyopathy – A COG‐ALTE03N1 Report - 7 month(s) ago
Background Anthracycline‐induced cardiomyopathy is a leading cause of premature death in childhood cancer survivors, presenting a need to understand the underlying pathogenesis. We sought to examin…
Source: www.ahajournals.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
LDHA, CD36, IL1R1, IL1R2 and MMP8/MMP9 expression is associated with anthracycline-induced #cardiomyopathy in childhood #cancer survivors. #AHAJournals @SmitaBhatia10 https://t.co/LPmD4Ys4xG https://t.co/BfbeQRsPRe
-
-
Mashup Score: 0FDA Issues CRL for Patisiran in Treatment of ATTR Cardiomyopathy - 7 month(s) ago
Announced on October 9, the decision to issue a CRL is based on the FDA’s belief the clinical meaningfulness of patisiran’s treatment effects for the cardiomyopathy of ATTR amyloidosis had not been established.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
BREAKING: @Alnylam has announced FDA issued a CRL for patisiran in treatment of ATTR-CM. Learn more: https://t.co/gySrqLHzhf #Cardiomyopathy
-
-
Mashup Score: 6Arise-HF - 7 month(s) ago
Evaluating the effectiveness and safety of an investigational drug called AT-001
Source: arisehf.comCategories: Cardiologists, Latest HeadlinesTweet-
The #ARISE-HF trial is evaluating the effectiveness and safety of an oral investigational drug called AT-001 in adults with Diabetic #Cardiomyopathy https://t.co/XojHMl3UiY @JJheart_doc @AndrewJSauer @JamalRanaMD @JavedButler1 @WilfriedMullens @DrMarthaGulati https://t.co/9KhDyDsVv4
-
-
Mashup Score: 26Mavacamten: a first-in-class myosin inhibitor for obstructive hypertrophic cardiomyopathy - 7 month(s) ago
Abstract. Mavacamten is a first-in-class, targeted, cardiac-specific myosin inhibitor approved by the US Food and Drug Administration for the treatment of adult
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet-
Mavacamten, a myosin inhibitor, is the first disease-specific treatment for obstructive hypertrophic cardiomyopathy. Read more in #EHJ. https://t.co/09mpPm2fOv #hypertrophic #cardiomyopathy #myosin #cardiotwitter @ESC_Journals @escardio https://t.co/3IWavg3LwN
-
-
Mashup Score: 1A 20-year population study of peripartum cardiomyopathy - 7 month(s) ago
AbstractBackground and Aims. The epidemiology of peripartum cardiomyopathy (PPCM) in Europe is poorly understood and data on long-term outcomes are lacking. A r
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet-
The epidemiology of peripartum cardiomyopathy in Europe is poorly understood and data on long-term outcomes are lacking. Read the latest 20-year population study of peripartum cardiomyopathy in #EHJ. https://t.co/pyTugGzy7a #cardiomyopathy #cardiotwitter @ESC_Journals @escardio https://t.co/yYoDCjJRMn
-
-
Mashup Score: 6Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines - 7 month(s) ago
AbstractBackground and Aims. Identifying patients with hypertrophic cardiomyopathy (HCM) who are candidates for implantable cardioverter defibrillator (ICD) imp
Source: academic.oup.comCategories: Cardiologists, Latest HeadlinesTweet-
The utility of late gadolinium enhancement to identify further risk stratification in hypertrophic cardiomyopathy. Read more in #EHJ. https://t.co/M5lc5m3L6l #cardiomyopathy #hypertophic #cardiotwitter @ESC_Journals @escardio https://t.co/4lgYq6Xjyd
-
-
Mashup Score: 0Heart Failure Society of America Annual Meeting - 7 month(s) ago
HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
We are in Cleveland where the #HFSA2023 meeting kicks off on Friday! Be sure to follow along throughout the weekend for the latest updates in #HeartFailure and #Cardiomyopathy! https://t.co/SYWtaaf4eB https://t.co/XKvP5pvFEj
-
-
Mashup Score: 3ACC Asia 2023 - American College of Cardiology - 7 month(s) ago
Meeting Type: Live Meetings – International Location: Edsa Shangri-La Manila, Manila, Philippines United by our shared commitment of transforming cardiovascular care, the American College of Cardiology (ACC) and the Philippine Heart Association invite you to join us for an innovative educational experience that will strengthen your everyday practice. ACC Asia 2023 is designed to deliver an engaging forum to critically examine evidence-based strategies as well as contemporary best practices and clinical
Source: www.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Dr. @purviparwani shares her thoughts on the use of advanced imaging for evaluation and ICD decision-making in patients with non ischemic #cardiomyopathy. Check out the full #ACCAsia agenda: https://t.co/VKQkkmTAvH #ACCIntl https://t.co/APWgmAtKPv
-
-
Mashup Score: 65
Abstract Heart failure and cardiomyopathy are significant contributors to pregnancy-related deaths, as maternal morbidity and mortality have been increasing over time. In this setting, the role of …
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet-
This #JACCHF state-of-the-art review is your go-to guide for caring for women with confirmed or suspected #cardiomyopathy during pregnancy: https://t.co/reNcWvbh9C #CardioObstetrics #HeartFailure #CardioTwitter @ersied727 @MKittlesonMD https://t.co/lLjdr5dYdi
-
Please join @StanfordCVI on Tue 10/17 at 12-1pm PST by Dr. Jose Pinto @FloridaState @FSUBiomed talk on #myofilament #variant in #cardiomyopathy Zoom link: https://t.co/oD1xyw95rv @StanfordDeptMed @Stanford_ChEMH @SeanM_Wu @StanCVFellows @BayAreaPostdocs @CardioNerds @ECI_ISHR https://t.co/llHW7MJ86V